92 related articles for article (PubMed ID: 24265033)
21. Ethnic disparities in adherence to breast cancer survivorship surveillance care.
Advani PS; Ying J; Theriault R; Melhem-Bertrand A; Moulder S; Bedrosian I; Tereffe W; Black S; Pini TM; Brewster AM
Cancer; 2014 Mar; 120(6):894-900. PubMed ID: 24258799
[TBL] [Abstract][Full Text] [Related]
22. G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey.
Link H; Kerkmann M; Holtmann L; Ortner P;
Support Care Cancer; 2019 Apr; 27(4):1459-1469. PubMed ID: 30374765
[TBL] [Abstract][Full Text] [Related]
23. Survival differences in breast cancer among racial/ethnic groups: a population-based study.
Boyer-Chammard A; Taylor TH; Anton-Culver H
Cancer Detect Prev; 1999; 23(6):463-73. PubMed ID: 10571656
[TBL] [Abstract][Full Text] [Related]
24. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy.
Hess C; Lee A; Fish K; Daly M; Cress RD; Mayadev J
Clin Breast Cancer; 2015 Jun; 15(3):212-8. PubMed ID: 25499694
[TBL] [Abstract][Full Text] [Related]
25. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
26. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.
Ikoma N; Cormier JN; Feig B; Du XL; Yamal JM; Hofstetter W; Das P; Ajani JA; Roland CL; Fournier K; Royal R; Mansfield P; Badgwell BD
Cancer; 2018 Mar; 124(5):998-1007. PubMed ID: 29393964
[TBL] [Abstract][Full Text] [Related]
27. Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
Griggs JJ; Culakova E; Sorbero ME; Poniewierski MS; Wolff DA; Crawford J; Dale DC; Lyman GH
J Clin Oncol; 2007 Jun; 25(18):2522-7. PubMed ID: 17577029
[TBL] [Abstract][Full Text] [Related]
28. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
29. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
30. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer treatment among women of different ethnicity in Hawaii.
Issell BF; Maskarinec G; Pagano I; Gotay CC
Cancer Invest; 2005; 23(6):497-504. PubMed ID: 16203657
[TBL] [Abstract][Full Text] [Related]
32. Racial and ethnic disparities in the diagnosis of breast cancer: changes in presenting stage in minority populations in Florida during 1981-2009.
Dosch AR; Koru-Sengul T; Miao F; Tannenbaum SL; Byrne MM; Wright JL
Breast Cancer Res Treat; 2014 Nov; 148(2):379-87. PubMed ID: 25301087
[TBL] [Abstract][Full Text] [Related]
33. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
34. HER2 status and disparities in luminal breast cancers.
Holowatyj AN; Ruterbusch JJ; Ratnam M; Gorski DH; Cote ML
Cancer Med; 2016 Aug; 5(8):2109-16. PubMed ID: 27250116
[TBL] [Abstract][Full Text] [Related]
35. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
36. Racial and Ethnic Disparity in Symptomatic Breast Cancer Awareness despite a Recent Screen: The Role of Tumor Biology and Mammography Facility Characteristics.
Mortel M; Rauscher GH; Murphy AM; Hoskins K; Warnecke RB
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1599-606. PubMed ID: 26199340
[TBL] [Abstract][Full Text] [Related]
37. A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand.
Seneviratne S; Campbell I; Scott N; Lawrenson R
BMC Health Serv Res; 2017 Jan; 17(1):64. PubMed ID: 28109301
[TBL] [Abstract][Full Text] [Related]
38. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.
Visser BC; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF
HPB (Oxford); 2012 Aug; 14(8):539-47. PubMed ID: 22762402
[TBL] [Abstract][Full Text] [Related]
39. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Kuper-Hommel M; Round G; Lawrenson R
BMC Cancer; 2014 Nov; 14():839. PubMed ID: 25406582
[TBL] [Abstract][Full Text] [Related]
40. Disparities in NCCN Guideline Compliant Care for Resectable Cholangiocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.
Tsilimigras DI; Dalmacy D; Hyer JM; Diaz A; Abbas A; Pawlik TM
Ann Surg Oncol; 2021 Dec; 28(13):8162-8171. PubMed ID: 34036428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
